Tradjenta
Tradjenta is a diabetes medication containing Linagliptin, available as 5mg tablets.
- Category
- Diabetes
- Active ingredient
- Linagliptin
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 5mg
Prescription rules on Tradjenta vary by country.
Details
- Conditions
- Type 2 diabetes mellitus
- Alternative Name
- Trajenta
- Therapeutic Class
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
- Pharmacological Class
- Gliptin
- Minor Side Effects
- nasopharyngitis, upper respiratory tract infection, headache
- Moderate Side Effects
- hypoglycaemia
- Dosage Forms
- Film-coated tablet
- Administration Route
- Oral use
- Prescription Status
- Available without prescription
- Manufacturer
- Boehringer Ingelheim
- Onset Time
- 1–2 weeks
- Duration
- 24 hours
- Storage Instructions
- Store at room temperature away from moisture and direct light.
- Drug Interactions
- rifampicin
- Age Restrictions
- Not recommended for children and adolescents under 18 years.